We are live on ! Find out more
TMC

Trellus Management Company Portfolio holdings

AUM $72.8M
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+28.52%
1 Year Est. Return
+4.5%
3 Year Est. Return
+267.94%
5 Year Est. Return
+673.14%
10 Year Est. Return
+719.68%
AUM
$121M
AUM Growth
+$23.6M
Cap. Flow
+$10.2M
Cap. Flow %
8.43%
Top 10 Hldgs %
61.51%
Holding
77
New
19
Increased
9
Reduced
12
Closed
25

Top Sells

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$9.56M
2
APPS icon
Digital Turbine
APPS
+$9.06M
3
AGEN
Agenus
AGEN
+$3M
4
ATRA icon
Atara Biotherapeutics
ATRA
+$2.46M
5
NKE icon
Nike
NKE
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Healthcare 13.47%
3 Utilities 6.53%
4 Consumer Discretionary 5.99%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
1
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$29.4M 24.25%
+70,000
New +$27M
VICR icon
2
Vicor
VICR
$8.33B
$12M 9.89%
129,945
AWK icon
3
American Water Works
AWK
$27B
$7.92M 6.53%
51,600
QDEL icon
4
QuidelOrtho
QDEL
$1.13B
$7.15M 5.9%
39,810
+22,900
+135% +$5.09M
GDX icon
5
CALL
VanEck Gold Miners ETF
GDX
$22.5B
$3.6M 2.97%
100,000
-30,000
-23% -$1.12M
AMT icon
6
American Tower
AMT
$83.5B
$3.37M 2.78%
15,000
-432
-3% -$100K
EBIX
7
DELISTED
Ebix Inc
EBIX
$3M 2.48%
79,000
-22,000
-22% -$619K
BABA icon
8
Alibaba
BABA
$276B
$2.91M 2.4%
12,500
QDEL icon
9
CALL
QuidelOrtho
QDEL
$1.13B
$2.69M 2.22%
15,000
-4,000
-21% -$889K
EIGR
10
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.54M 2.09%
6,880
+213
+3% +$61.1K
MNDT
11
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.42M 2%
105,096
DIS icon
12
Walt Disney
DIS
$171B
$2.39M 1.97%
13,200
PRTK
13
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.13M 1.76%
340,000
+40,000
+13% +$235K
CSTM icon
14
Constellium
CSTM
$3.76B
$2.1M 1.73%
150,000
MILE
15
DELISTED
Metromile, Inc. Common Stock
MILE
$1.8M 1.48%
+115,500
New +$1.55M
WPRT
16
Westport Fuel Systems
WPRT
$31.9M
$1.75M 1.45%
32,930
-3,870
-11% -$122K
PRTS icon
17
CarParts.com
PRTS
$42.6M
$1.74M 1.43%
14,000
+2,000
+17% +$258K
BHVN
18
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.71M 1.41%
+20,000
New +$1.69M
LRN icon
19
CALL
Stride
LRN
$4.16B
$1.7M 1.4%
+80,000
New +$1.99M
PI icon
20
Impinj
PI
$4.24B
$1.66M 1.37%
39,616
BLK icon
21
Blackrock
BLK
$167B
$1.44M 1.19%
2,000
WIFI
22
DELISTED
Boingo Wireless, Inc.
WIFI
$1.44M 1.18%
112,800
+12,800
+13% +$151K
JPM icon
23
JPMorgan Chase
JPM
$916B
$1.4M 1.15%
11,000
LPSN icon
24
LivePerson
LPSN
$22M
$1.34M 1.11%
1,440
SLNO
25
DELISTED
Soleno Therapeutics
SLNO
$1.28M 1.06%
44,174
+16,412
+59% +$474K

Similar funds

Trellus Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, Trellus Management Company held 77 positions worth $121M, up 24% from $97.6M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Trellus Management Company deployed $10.2M of net new capital in Q4 2020, opening 19 new positions and adding to 9 existing holdings. Its largest new stake was Metromile, Inc. Common Stock: 115,500 shares worth $1.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 30% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Atara Biotherapeutics, an estimated $2.46M trimmed.

  • Trellus Management Company's largest Q4 2020 buy was Metromile, Inc. Common Stock: 115,500 shares worth $1.8M.
  • Trellus Management Company added most to QuidelOrtho in Q4 2020, an estimated $5.09M increase.
  • Trellus Management Company's biggest Q4 2020 reduction was Atara Biotherapeutics, cutting an estimated $2.46M.
  • Trellus Management Company fully exited Opko Health in Q4 2020, selling an estimated $9.56M.
  • Trellus Management Company's ten largest holdings make up 62% of its $121M portfolio in Q4 2020.
  • Trellus Management Company opened 19 new positions and closed 25 in Q4 2020.
  • Trellus Management Company's portfolio value rose 24% quarter-over-quarter to $121M.

Based on Trellus Management Company's 13F filing for Q4 2020, filed 10 Feb 2021.